Aroa Biosurgery Limited (AROAF)

Aroa Biosurgery Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	172	91	125	242	199	275
Market Cap Growth	37.50%	-26.61%	-48.43%	21.32%	-27.50%	-
Enterprise Value	161	83	107	215	156	258
Last Close Price	0.52	0.40	-	-	-	-
PS Ratio	3.27	1.91	3.02	6.09	7.22	17.59
PB Ratio	3.20	1.73	2.19	3.79	2.85	6.72
P/TBV Ratio	3.77	2.06	2.63	4.51	3.44	9.72
EV/Sales Ratio	2.87	1.73	2.60	5.43	5.65	16.50
EV/EBITDA Ratio	51.52	573.12	-	-	-	-
Debt / Equity Ratio	0.08	0.07	0.08	0.07	0.06	0.28
Debt / EBITDA Ratio	1.39	4.74	-	9.83	-	-
Asset Turnover	0.84	0.77	0.61	0.55	0.41	0.36
Inventory Turnover	1.56	1.48	1.56	2.24	2.47	1.79
Quick Ratio	5.60	5.58	6.21	9.06	11.11	2.89
Current Ratio	6.52	6.62	7.26	9.88	11.90	3.19
Return on Equity (ROE)	-1.97%	-4.06%	-10.80%	-0.39%	-10.55%	-58.13%
Return on Assets (ROA)	0.37%	-1.66%	-5.86%	-1.70%	-4.97%	-9.93%
Return on Capital Employed (ROCE)	0.60%	-3.00%	-10.50%	-2.90%	-7.20%	-15.50%
Earnings Yield	-0.62%	-2.36%	-5.10%	-0.10%	-2.93%	-4.89%
FCF Yield	1.70%	-3.02%	-5.23%	-2.54%	-5.57%	-1.60%
Buyback Yield / Dilution	-0.19%	-0.31%	-0.27%	-0.22%	-13.90%	-10620.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.